Business Wire

NC-PERCONA

20.8.2024 14:31:27 CEST | Business Wire | Press release

Share
Percona Augments Corporate Governance with the Appointment of Two New Independent Directors

Percona, a global leader in enterprise-grade open source database software and services, today announced the addition of two preeminent technology business leaders – John Newton, Co-Founder of Alfresco and Documentum, and Rob Young, a veteran of the open source software ecosystem – as independent directors to its board. The appointments expand the wealth of business strategy, industry expertise and strategic counsel the Percona board offers CEO Ann Schlemmer and her leadership team.

John Newton brings over 40 years of experience in the enterprise software industry, having played a pivotal role in the development and success of numerous companies. A serial entrepreneur, John co-founded Documentum, which was acquired by EMC in 2003, and Alfresco, an open source platform for information management, which had a successful exit with its sale to Hyland Software in 2020. John began his career as one of the founding engineers at Ingres Corporation, where he led the development of their database management system. His innovative contributions to data and information management have earned him several prestigious awards, including recognition as a Technology Pioneer at the World Economic Forum in Davos in 2006 and the Award of Merit from the Association for Intelligent Information Management (AIIM) in 2023. John holds a BS in Electrical Engineering and Computer Science from the University of California, Berkeley, and has served on the boards of several leading companies, including Alfresco, Wideworks, and AIIM.

Rob Young is a seasoned business and technology executive with four decades of experience in building and delivering enterprise solutions through an open source development and delivery model. During his career, Rob has held key technical and leadership positions across various industries, including finance, transportation, healthcare, public utilities, and commercial software and services. Rob has been a driving force in establishing open source software as a trusted foundation for digital transformation. He was instrumental in developing growth strategies and business models focused on value-added differentiation and customer satisfaction in numerous strategic roles at MySQL AB, MongoDB, Percona, RedHat, and DigitalOcean. Notably, while with MySQL AB, Rob led the design, development, and delivery of MySQL Enterprise, which quadrupled the company's revenue in just two years and culminated in a $1 billion acquisition by Sun Microsystems. Rob holds a Bachelor of Science in Economics and Math from the University of Louisville and resides in Louisville, KY.

“We are honored to welcome John Newton and Rob Young to our board,” said Ann Schlemmer, CEO of Percona. “Their extensive experience and deep understanding of the industry will be invaluable as we continue to innovate and deliver world-class solutions to our customers. Their leadership and vision will be crucial as we navigate the opportunities and challenges ahead, ensuring we maintain the highest standards of corporate governance.”

These appointments come at a pivotal time for Percona as the company reaffirms its commitment to cloud-native development with the introduction of Percona Everest and expands its footprint into the Redis ecosystem through its involvement with the Linux Foundation’s Valkey Project. With the addition of John Newton and Rob Young, Percona is well-positioned to accelerate growth and continue its mission of empowering enterprises with robust, reliable, and scalable open source database solutions.

About Percona

Percona is a world-class open source database software, support, and services company. The organization is dedicated to helping businesses ensure their databases — and the applications that depend on them — are secure, compliant, performant, and highly available. Through a unique combination of database expertise and enterprise-grade open source software, Percona empowers organizations with the freedom to choose, the freedom to create, and the freedom to innovate with speed as they grow. For more information, visit www.percona.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240815431864/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sharjah Ruler Receives Portugal’s Grand Collar of Order of Camões31.1.2026 18:27:00 CET | Press release

His Excellency Marcelo Rebelo de Sousa, President of the Portuguese Republic, awarded His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, the Grand Collar of the Order of Camões (Grande Colar da Ordem de Camões), the highest sovereign cultural order in Portugal. His Highness is the first Arab figure to receive the Order of Camões and the sixth recipient worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131119526/en/ Sharjah Ruler receives Portugal’s Grand Collar of Order of Camões (Photo: AETOSWire) The honour was conferred during a ceremony hosted by the Portuguese President at the Presidential Palace in Lisbon. The event was attended by Sheikha Bodour bint Sultan Al Qasimi, Chairperson of the Sharjah Book Authority, alongside senior officials. The ceremony recognised His Highness’s prominent global stature, as a leading figure in culture, intellectual thought and in

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye